2q1l

From Proteopedia

proteopedia linkproteopedia link

Revision as of 23:06, 26 December 2010 (edit) OCA (Talk | contribs) m (Protected "2q1l" [edit=sysop:move=sysop]) ← Previous diff		Revision as of 05:57, 15 February 2012 (edit) (undo) OCA (Talk | contribs) Next diff →
Line 25:		Line 25:
	==Reference==		==Reference==
-	<ref group="xtra">PMID:17574412</ref><references group="xtra"/>	+	<ref group="xtra">PMID:017574412</ref><references group="xtra"/>
	[[Category: Homo sapiens]]		[[Category: Homo sapiens]]
	[[Category: Finzel, B C.]]		[[Category: Finzel, B C.]]

---

Revision as of 05:57, 15 February 2012

Template:STRUCTURE 2q1l

Contents 1 Design and Synthesis of Pyrrole-based, Hepatoselective HMG-CoA Reductase Inhibitors 2 About this Structure 3 See Also 4 Reference

Design and Synthesis of Pyrrole-based, Hepatoselective HMG-CoA Reductase Inhibitors

Template:ABSTRACT PUBMED 17574412

About this Structure

2q1l is a 4 chain structure of HMG-CoA Reductase with sequence from Homo sapiens. Full crystallographic information is available from OCA.

See Also

• HMG-CoA Reductase

Reference

• Pfefferkorn JA, Song Y, Sun KL, Miller SR, Trivedi BK, Choi C, Sorenson RJ, Bratton LD, Unangst PC, Larsen SD, Poel TJ, Cheng XM, Lee C, Erasga N, Auerbach B, Askew V, Dillon L, Hanselman JC, Lin Z, Lu G, Robertson A, Olsen K, Mertz T, Sekerke C, Pavlovsky A, Harris MS, Bainbridge G, Caspers N, Chen H, Eberstadt M. Design and synthesis of hepatoselective, pyrrole-based HMG-CoA reductase inhibitors. Bioorg Med Chem Lett. 2007 Aug 15;17(16):4538-44. Epub 2007 Jun 6. PMID:17574412 doi:10.1016/j.bmcl.2007.05.096